Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAStem Cell Injection for meniscal injury
CTR20220157Phase 2Active
- Sponsor
- Zehui Chenxing
- Start
- Apr 2022
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CAStem cells in meniscal tear, sponsored by Zehui Chenxing. Started Apr 2022; status: active.
02
Drugs
CAStem cells
03
Conditions
meniscal tear
Beyond the preview
Go deeper on CTR20220157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220157.